Q32 Bio Inc. Quarterly Operating Income (Loss) in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Q32 Bio Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2017 to Q3 2024.
  • Q32 Bio Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$18.8M, a 141% decline year-over-year.
  • Q32 Bio Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$131M, a 129% decline year-over-year.
  • Q32 Bio Inc. annual Operating Income (Loss) for 2023 was -$101M, a 23.9% increase from 2022.
  • Q32 Bio Inc. annual Operating Income (Loss) for 2022 was -$133M, a 38.9% decline from 2021.
  • Q32 Bio Inc. annual Operating Income (Loss) for 2021 was -$95.9M, a 26.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$131M -$18.8M -$11M -141% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$120M -$17.9M -$10.6M -146% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$109M -$14.8M -$7.47M -101% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$101M -$79M -$44.5M -129% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$56.9M -$7.8M +$25.1M +76.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$82M -$7.28M +$21M +74.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$103M -$7.37M +$30.2M +80.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$133M -$34.5M -$869K -2.58% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$132M -$32.9M -$2.2M -7.18% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$130M -$28.3M +$2.25M +7.35% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$132M -$37.6M -$36.5M -3286% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$95.9M -$33.6M -$3.82M -12.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$92.1M -$30.7M -$2.39M -8.45% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$89.7M -$30.6M +$5.15M +14.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$94.9M -$1.11M +$35.4M +97% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$130M -$29.8M -$4.24M -16.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$126M -$28.3M +$3.02M +9.64% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$129M -$35.7M -$7.72M -27.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$121M -$36.5M -$11.4M -45.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$110M -$25.6M -$5.39M -26.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$105M -$31.3M -$15.7M -100% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$88.9M -$28M -$14.6M -108% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$74.4M -$25.1M -$14.4M -135% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$59.9M -$20.2M -$7.91M -64.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$52M -$15.6M -$8.97M -135% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$43M -$13.4M -$7.38M -122% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$35.7M -$10.7M -$6M -128% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$29.7M -$12.3M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$6.66M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$6.04M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$4.69M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.